The new piperazine derivatives are modulators of TRPML and are useful in treating disorders related to TRPML activities such as lysosome storage diseases, muscular dystrophy, age-related common neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS) related diseases, and ageing.
新的
哌嗪衍
生物是 TRPML 的调节剂,可用于治疗与 TRPML 活性有关的疾病,如溶酶体贮积症、肌肉萎缩症、与年龄有关的常见神经退行性疾病、与氧化应激或活性氧(ROS)有关的疾病以及老化。